Tech Center 1600 • Art Units: 1642
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18563348 | IMMUNOMODULATION OF TUMOR MICROENVIRONMENT | Non-Final OA | CLS THERAPEUTICS LIMITED |
| 18467957 | ANTI-HUMAN LAIR1 ANTIBODIES | Non-Final OA | TRex Bio, Inc. |
| 17796289 | STABLE ANTI-PD-1 ANTIBODY PHARMACEUTICAL FORMULATIONS | Non-Final OA | SAMSUNG BIOEPIS CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy